Why the study?
Does levosimendan reduce mortality in adult patients undergoing coronary revascularization?
Does levosimendan reduce mortality in adult patients undergoing coronary revascularization?
Levosimendan may significantly reduce mortality and improve secondary outcomes such as cardiac index and length of ICU stay in patients undergoing coronary revascularization.
No takes yet. Share an insight, caveat, or question.
May support levosimendan after coronary revascularization; extends meta-analytic evidence but requires RCT confirmation.
Maharaj et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: